Ironwood Pharmaceuticals to acquire Swiss biotech company VectivBio
Ironwood Pharmaceuticals, a gastrointestinal (GI)-focused healthcare company, has agreed to acquire VectivBio Holding AG, a Switzerland-based biotech company, listed on the Nasdaq, for around $1 billion, including the latter’s debt. Shareholders of VectivBio will be paid $17 per share in cash. VectivBio is a clinical-stage biopharmaceutical company headquartered in Basel, specializing in the development of […]